Outpatient Management of Type 1 Diabetes
The recommended outpatient management for type 1 diabetes should include multiple daily injections (MDI) of insulin or continuous subcutaneous insulin infusion (CSII/insulin pump) as the cornerstone of treatment, along with continuous glucose monitoring to improve glycemic outcomes and minimize hypoglycemia risk. 1, 2
Insulin Therapy Framework
Insulin Regimen Options
- First-line therapy options:
Insulin Selection
- Basal insulin: Insulin analogs are preferred over human insulins to minimize hypoglycemia risk 1, 2
- Prandial insulin: Rapid-acting analogs (aspart, glulisine, lispro) or faster-acting insulin aspart are preferred over regular human insulin 1, 3
- Insulin distribution: Typically 50% basal insulin and 50% bolus insulin of total daily dose 4
Glucose Monitoring
- Early implementation of continuous glucose monitoring (CGM) is strongly recommended 1, 2
- For patients without CGM, frequent self-monitoring of blood glucose is essential 5
- Target HbA1c <7% for most nonpregnant adults 3
- For children with T1DM, target HbA1c <7.5% 5
Patient Education Requirements
- Carbohydrate counting for meal insulin dosing 1
- Matching mealtime insulin to carbohydrate intake, and additionally to fat and protein intake 1
- Modifying insulin doses based on:
- Pre-meal blood glucose levels
- Glycemic trends (if CGM available)
- Anticipated physical activity
- Sick day management 1
Nutritional Management
- Medical nutrition therapy can lower HbA1c by up to 1.9% 4
- For patients on MDI or insulin pump:
- Take mealtime insulin before eating
- Meals can be consumed at different times
- Adjust insulin dose if physical activity is performed within 1-2 hours of mealtime insulin 1
Hypoglycemia Prevention and Management
- Prescribe glucagon for all individuals taking insulin 1
- Educate family members, caregivers, and school personnel on glucagon administration 1
- Prefer glucagon preparations that don't require reconstitution 1
- For hypoglycemia treatment, use 15-20g of glucose (glucose tablets preferred) 1
- Recheck blood glucose after 15-20 minutes and repeat treatment if hypoglycemia persists 1
Monitoring and Follow-up
- Reevaluate insulin treatment plan every 3-6 months 1
- Screen regularly for associated conditions:
Special Considerations
- Avoid sliding-scale insulin as the sole treatment strategy 1
- For patients with frequent nocturnal hypoglycemia or hypoglycemia unawareness, consider sensor-augmented low glucose suspend threshold pump 1
- For physical activity:
- Carry carbohydrate source to prevent hypoglycemia
- Consider reducing insulin dose if activity occurs within 1-2 hours of insulin injection 1
By implementing this comprehensive approach to type 1 diabetes management with appropriate insulin therapy, glucose monitoring, patient education, and regular follow-up, patients can achieve optimal glycemic control while minimizing the risk of hypoglycemia and other complications.